| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Endocrinology and Metabolism, Vol 258, Issue 5 E841-E849, Copyright © 1990 by American Physiological Society
ARTICLES |
G. K. Hendrick, R. T. Frizzell, P. E. Williams and A. D. Cherrington
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
The aim of this study was to determine if glucagon can stimulate hepatic glucose production in prolonged fasted (7 days) animals. Two protocols were used; in one ("hormone replacement"; n = 4), intraportal basal replacement amounts of insulin and glucagon were given during a somatostatin infusion, whereas, in the other ("glucagon excess"; n = 5) basal insulin was given along with somatostatin and excess glucagon. Plasma insulin levels were similar and constant throughout both protocols (6 +/- 1 microU/ml). The plasma glucagon was basal in the hormone-replacement protocol (49 +/- 9 pg/ml) but rose from 46 +/- 7 to 448 +/- 35 pg/ml (P less than 0.05) in the other protocol. Plasma glucose levels and the rates of glucose production were unchanged during hormone replacement but rose from 100 +/- 5 to 199 +/- 28 mg/dl and from 1.5 +/- 0.1 to a peak of 5.6 +/- 0.2 mg.kg-1.min-1 at 15 min (P less than 0.05) and an eventual plateau of 2.7 +/- 0.2 mg.kg-1.min-1 (P less than 0.05) in response to glucagon excess. Because of the sluggish increase in gluconeogenic parameters, the early marked rise in glucose production was attributable to increased glycogenolysis. Eventually, however, the gluconeogenic rate rose, with net hepatic uptake of alanine increasing 50% and fractional alanine extraction doubling. Gluconeogenic efficiency and conversion increased in response to glucagon excess by 0.30 +/- 0.05 and 159 +/- 48%, respectively, although it should be noted that these parameters rose 0.15 +/- 0.06 and 150 +/- 49% in the hormone-replacement protocol. In conclusion, even after a prolonged fast physiological glucagon can cause hyperglycemia.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  M. Nishizawa, M. Shiota, M. C. Moore, S. M. Gustavson, D. W. Neal, and A. D. Cherrington Intraportal administration of neuropeptide Y and hepatic glucose metabolism Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1197 - R1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. S. Johnson, D. S. Edgerton, T. Rodewald, M. Scott, B. Farmer, D. Neal, and A. D. Cherrington Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1085 - E1091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-Y. Chueh, C. Malabanan, and O. P. McGuinness Impact of portal glucose delivery on glucose metabolism in conscious, unrestrained mice Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1206 - E1211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. DiCostanzo, M. C. Moore, M. Lautz, M. Scott, B. Farmer, C. A. Everett, J. G. Still, A. Higgins, and A. D. Cherrington Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E46 - E52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Moore, C. A. DiCostanzo, D. Dardevet, M. Lautz, B. Farmer, and A. D. Cherrington Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E556 - E563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Moore, C. A. DiCostanzo, D. Dardevet, M. Lautz, B. Farmer, D. W. Neal, and A. D. Cherrington Portal infusion of a selective serotonin reuptake inhibitor enhances hepatic glucose disposal in conscious dogs Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1057 - E1063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cardin, M. J. Pagliassotti, M. C. Moore, D. S. Edgerton, M. Lautz, B. Farmer, D. W. Neal, and A. D. Cherrington Vagal cooling and concomitant portal norepinephrine infusion do not reduce net hepatic glucose uptake in conscious dogs Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R742 - R748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Moore, S. Cardin, D. S. Edgerton, B. Farmer, D. W. Neal, M. Lautz, and A. D. Cherrington Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E226 - E233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, S. Vaughan, E. P. Donahue, P. Flakoll, and A. D. Cherrington Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E534 - E544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Goldstein, L. Rossetti, B. A. J. Palmer, R. Liu, D. Massillon, M. Scott, D. Neal, P. Williams, B. Peeler, and A. D. Cherrington Effects of fasting and glucocorticoids on hepatic gluconeogenesis assessed using two independent methods in vivo Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E946 - E957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Bischof, E. Bernroider, M. Krssak, M. Krebs, H. Stingl, P. Nowotny, C. Yu, G. I. Shulman, W. Waldhausl, and M. Roden Hepatic Glycogen Metabolism in Type 1 Diabetes After Long-Term Near Normoglycemia Diabetes, January 1, 2002; 51(1): 49 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Connolly, L. C. Holste, L. N. Aglione, D. W. Neal, D. B. Lacy, M. S. Smith, M. P. Diamond, A. D. Cherrington, and J.-L. Chiasson Alterations in basal glucose metabolism during late pregnancy in the conscious dog Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1166 - E1177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Galassetti, Y. Koyama, R. H. Coker, D. B. Lacy, A. D. Cherrington, and D. H. Wasserman Role of a negative arterial-portal venous glucose gradient in the postexercise state Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1038 - E1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Galassetti, R. H. Coker, D. B. Lacy, A. D. Cherrington, and D. H. Wasserman Prior exercise increases net hepatic glucose uptake during a glucose load Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1022 - E1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Galassetti, K. S. Hamilton, F. K. Gibbons, D. P. Bracy, D. B. Lacy, A. D. Cherrington, and D. H. Wasserman Effect of fast duration on disposition of an intraduodenal glucose load in the conscious dog Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E543 - E552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Halseth, P. J. Flakoll, E. K. Reed, A. B. Messina, M. G. Krishna, D. B. Lacy, P. E. Williams, and D. H. Wasserman Effect of physical activity and fasting on gut and liver proteolysis in the dog Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1073 - E1082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shiota, P. A. Jackson, H. Bischoff, M. McCaleb, M. Scott, M. Monohan, D. W. Neal, and A. D. Cherrington Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E868 - E879. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
